Catherine Coste - Net Worth and Insider Trading

Catherine Coste Net Worth

The estimated net worth of Catherine Coste is at least $16,329 dollars as of 2024-11-11. Catherine Coste is the Audit Committee Chairperson of Biomerica Inc and owns about 43,790 shares of Biomerica Inc (BMRA) stock worth over $16,329. Details can be seen in Catherine Coste's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Catherine Coste has not made any transactions after 2023-01-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Catherine Coste

To

Catherine Coste Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Catherine Coste owns 3 companies in total, including Biomerica Inc (BMRA) , Minerva Surgical Inc (UTRS) , and Renalytix PLC (RNLXY) .

Click here to see the complete history of Catherine Coste’s form 4 insider trades.

Insider Ownership Summary of Catherine Coste

Ticker Comapny Transaction Date Type of Owner
BMRA Biomerica Inc 2023-01-26 director
UTRS Minerva Surgical Inc 2021-10-21 director
RNLXY Renalytix PLC 2023-07-01 director

Catherine Coste Latest Holdings Summary

Catherine Coste currently owns a total of 1 stock. Catherine Coste owns 43,790 shares of Biomerica Inc (BMRA) as of January 26, 2023, with a value of $16,329.

Latest Holdings of Catherine Coste

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMRA Biomerica Inc 2023-01-26 43,790 0.37 16,329

Holding Weightings of Catherine Coste


Catherine Coste Form 4 Trading Tracker

According to the SEC Form 4 filings, Catherine Coste has made a total of 2 transactions in Biomerica Inc (BMRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Biomerica Inc is the acquisition of 2,190 shares on January 26, 2023, which cost Catherine Coste around $6,482.

Insider Trading History of Catherine Coste

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Catherine Coste Trading Performance

GuruFocus tracks the stock performance after each of Catherine Coste's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catherine Coste is -12.67%. GuruFocus also compares Catherine Coste's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catherine Coste within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Catherine Coste's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Catherine Coste

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.19 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.95 LIMIT LIMIT LIMIT LIMIT LIMIT

Catherine Coste Ownership Network

Ownership Network List of Catherine Coste

No Data

Ownership Network Relation of Catherine Coste

Insider Network Chart

Catherine Coste Owned Company Details

What does Biomerica Inc do?

Who are the key executives at Biomerica Inc?

Catherine Coste is the director of Biomerica Inc. Other key executives at Biomerica Inc include director & Cheif Executive Officer Zacharys Irani , Chief Financial Officer Gary Lu , and Chief Financial Officer Steven Sloan .

Biomerica Inc (BMRA) Insider Trades Summary

Over the past 18 months, Catherine Coste made no insider transaction in Biomerica Inc (BMRA). Other recent insider transactions involving Biomerica Inc (BMRA) include a net purchase of 2,400 shares made by Zacharys Irani ,

In summary, during the past 3 months, insiders sold 0 shares of Biomerica Inc (BMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biomerica Inc (BMRA) were sold and 2,400 shares were bought by its insiders, resulting in a net purchase of 2,400 shares.

Biomerica Inc (BMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biomerica Inc Insider Transactions

No Available Data

Catherine Coste Mailing Address

Above is the net worth, insider trading, and ownership report for Catherine Coste. You might contact Catherine Coste via mailing address: 966 Ocho Rios Dr, Danville Ca 94526.